🇺🇸 FDA
Pipeline program

Placebo

SPON-804-10

Phase 2 small_molecule terminated

Quick answer

Placebo for Metastatic Breast Cancer is a Phase 2 program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).

Program details

Company
Cardiff Oncology
Indication
Metastatic Breast Cancer
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials